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Background
When the myocardium is injured by an acute infarction, a
fibrous, non-contractile scar develops, because mature
cardiac tissue cannot effectively regenerate. In patients this
often results in congestive heart failure, one of the major
health problems in the developed world. Although
multipotent cardiac stem cells, which could support myo-
cardial regeneration, were recently identified, their lim-
ited availability prevents therapeutic applications. More
readily available stem cell populations derived from other
tissues, such as undifferentiated skeletal myocytes (myob-
lasts) or bone marrow-derived adult stem cells, have been
shown to be capable of repairing cardiac damage in ani-
mal models. These cell types, however, have a very limited
capacity to transdifferentiate into functional cardiomyo-
cytes after transplantation into the heart. This fact cer-
tainly hampers their beneficial therapeutic effects. A
strategy to overcome this problem would be the induction
of cardiomyogenic function in stem cells prior to trans-
plantation. Here, we tried two different in vitro strategies
to achieve this goal in skeletal myoblasts.
Materials and methods
Mouse C2C12 skeletal myoblasts were incubated in differ-
entiation media preconditioned by primary cardiomyo-
cyte cultures (cardiac preconditioning), or treated with the
cardiomyogenic small molecule cardiogenol C for 2–14
days. Thereafter, their electrophysiological properties
were measured using the whole cell patch clamp tech-
nique, and compared with those of untreated control
cells.
Results
Simulation of a cardiac cell environment by "cardiac pre-
conditioning" altered the Na+ current activation and inac-
tivation properties of C2C12 cells from skeletal muscle to
more cardiac-like ones. Tetrodotoxin and RT-PCR experi-
ments suggest that an upregulation of the expression of
the cardiac sodium channel isoform NaV1.5 versus the
skeletal muscle isoform NaV1.4 is responsible for the
observed changes in sodium current function. Similar
effects on the Na+ currents of C2C12 cells were observed
in cells treated with the cardiomyogenic small molecule
cardiogenol C.
Conclusion
We conclude that cardiac preconditioning and treatment
with cardiogenol C affect the electrophysiological proper-
ties of skeletal myoblasts. Such strategies may be useful to
generate myoblasts with more cardiac-like electrophysio-
logical properties.
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